A bispecific soluble receptor fusion protein that targets TNF-α and IL-21 for synergistic therapy in inflammatory arthritis.
Park JS, Yoo SH, Lim MA, Ryu JG, Oh HJ, Hwang SH, Yang S, Jung KA, Yoon S, Park BC, Park SH, Kim HY, Cho ML, Park YW.
Park JS, et al. Among authors: park bc, park yw, park sh.
FASEB J. 2020 Jan;34(1):248-262. doi: 10.1096/fj.201900816RR. Epub 2019 Nov 21.
FASEB J. 2020.
PMID: 31914604